Pharmacy
Hello, Mary O'connor
Manage E-mail  |  Logout

Article ID

Home
General Pharmacy
Messages (0)
Conferences
Jobs
Newsletters
My Library
Topics in
Pharmacy
        Adverse Drug Reactions
        Antimicrobials
        Basic Science
        Cardiac/Hypertension
        Chemotherapy/Oncology
        Complementary Medicine
        Dosing
        Drug Approvals
        Drug Interactions
        Drug Resistance
        Drug Trials
        Drug/Product Alerts
        Economics of Medicine
        Major Studies
        Neuro/Psych pharmacology
        Other Drugs
        Over The Counter (OTC)
        Pain Management
        Patient Counseling
        Pharmacoeconomics
        Pharmacokinetics
        Pharmacy Management
        Popular Press
        Stomach/GI
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor

Articles: Chemotherapy/Oncology



Latest (3) Month's Top Read  
Receive free subspecialty "5-minute updates" via email

Prior Articles


Safety and toxicity of intrathecal liposomal cytarabine (Depocyte) in children and adolescents with recurrent or refractory brain tumors: a multi-institutional retrospective study
Anti-Cancer Drugs, 09/11/09
Sponsor
Gemcitabine induced digital ischaemia and necrosis
European Journal of Cancer Care, 09/11/09
Interactions between antiepileptic and chemotherapeutic drugs in children with brain tumors: Is it time to change treatment
Pediatric Blood & Cancer, 09/11/09
Combined treatment with TNF-[alpha]/gefitinib alleviates the resistance to gefitinib in PC-9 cells
Anti-Cancer Drugs, 09/11/09
Acute Myeloid Leukemia With Translocation (8;21) or Inversion (16) in Elderly Patients Treated With Conventional Chemotherapy: A Collaborative Study of the French CBF-AML Intergroup
Journal of Clinical Oncology, 09/11/09
Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol
Pediatric Blood & Cancer, 09/11/09
Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study
Journal of Cancer Research & Clinical Oncology, 09/10/09
Imatinib in Gastrointestinal Stromal Tumor: Does Treatment Duration Matter
Oncology (Karger), 09/10/09
Allopurinol mouth rinse for prophylaxis of fluorouracil-induced mucositis
European Journal of Cancer Care, 09/10/09
Expression of multidrug resistance-associated ABC transporters in B-CLL is independent of ZAP70 status
Journal of Cancer Research & Clinical Oncology, 09/10/09
The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy
Cancer Immunology, Immunotherapy, 09/10/09
Assess the risk of chemotherapy-induced nausea and vomiting, then choose the appropriate prophylactic regimen
Drugs & Therapy Perspectives, 09/10/09
The efficacy of oral ondansetron and dexamethasone for the prevention of acute chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy – a retrospective audit
European Journal of Cancer Care, 09/09/09
Does Preoperative Core Needle Biopsy Increase Surgical Site Infections in Breast Cancer Surgery? Randomized Study of Antibiotic Prophylaxis
Surgical Infections, 09/09/09
Retrospective cost analysis of management of febrile neutropenia in cancer patients in Spain
Current Medical Research and Opinion, 09/08/09
Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study
Clinical Cancer Research, 09/08/09
Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature
European Journal of Cancer Care, 09/08/09
Clinical features of oral chemotherapy: results of a longitudinal prospective study of breast and colorectal cancer patients receiving capecitabine in the UK
European Journal of Cancer Care, 09/08/09
Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer
Journal of Clinical Oncology, 09/04/09
Frequent Pathologic Complete Responses in Aggressive Stages II to III Breast Cancers With Every-4-Week Carboplatin and Weekly Paclitaxel With or Without Trastuzumab: A Brown University Oncology Group Study
Journal of Clinical Oncology, 09/04/09

Receive free subspecialty "5-minute updates" via email
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist more...
250 Available Pages
First    Prev    10      11      12      13      14      15      16      17      18      19      Next      Last
Sponsor

Read a Different Specialty

Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pain
Pediatrics
Practice Management
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Pharmacy Articles Profession Index

Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2009 MDLinx, Inc.